Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.76 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.76 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.65 |
| ▸ | TUBB | P07437 | 1/20 | 0.65 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | XDH | P47989 | 1/20 | 0.65 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.65 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.65 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.65 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.65 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1764300 | 0.88 | ABCG2 (0.73) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| SCHEMBL5073336 | 0.88 | ABCG2 (0.84) | ADORA3SLC22A2SLC22A1MEN1KMT2A | |
| SCHEMBL2727281 | 0.88 | ABCG2 (0.83) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| SCHEMBL774317 | 0.88 | ADORA3 (0.72) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| SCHEMBL29549851 | 0.87 | ALDH1A1 (0.60) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| Tangeretin SCHEMBL23629557 | 0.87 | ALDH1A1 (0.70) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| Tetramethylkaempferol SCHEMBL1664159 | 0.86 | ADORA3 (1.00) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 | |
| Hexamethoxyflavone SCHEMBL30232628 | 0.86 | MEN1 (0.74) | ALDH1A1MEN1KMT2AABCG2CYP3A4 | |
| Hexamethoxyflavone SCHEMBL987569 | 0.86 | MEN1 (0.74) | ALDH1A1MEN1KMT2AABCG2CYP3A4 | |
| SCHEMBL16894654 | 0.86 | ADORA3 (0.72) | ADORA3SLC22A2SLC22A1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| EP-4090167-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | Apeel Technology, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| US-20220330565-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. | 2022-10-20 | — | — | US | claimed |
| WO-2022217089-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. (US) | 2022-10-13 | — | — | WO | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20250204541-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. | 2025-06-26 | — | — | US | disclosed |
| WO-2025024302-A1 | EDIBLE COATING COMPOSITIONS | APEEL TECHNOLOGY, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | disclosed |
| WO-2024107841-A1 | EDIBLE COATING COMPOSITIONS | APEEL TECHNOLOGY, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240156117-A1 | EDIBLE COATING COMPOSITIONS | APEEL TECH INC (US) | 2024-05-16 | — | — | US | disclosed |
| CN-117769354-A | Barrier film composition | 阿比尔技术公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2022212597-A1 | BARRIER FILM COMPOSITION | APEEL TECHNOLOGY, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| US-20220312803-A1 | EDIBLE BARRIER FILM COMPOSITION | APEEL TECHNOLOGY, INC. | 2022-10-06 | — | — | US | disclosed |
| WO-2022212556-A1 | EDIBLE BARRIER FILM COMPOSITION | APEEL TECHNOLOGY, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-113874052-A | Method for preventing calcific deposit formation and inactivating xenoantigen in biological matrices | 生物相容性创新责任有限公司 | 2021-12-31 | — | — | CN | disclosed |
| US-20180042899-A1 | Method of Treating Transplant Rejection and Autoimmune Diseases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-15 | — | — | US | disclosed |
| US-20140050694-A1 | Method of Treating Transplant Rejection and Autoimmune Diseases | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-02-20 | — | — | US | disclosed |
| US-20090269772-A1 | SYSTEMS AND METHODS FOR IDENTIFYING COMBINATIONS OF COMPOUNDS OF THERAPEUTIC INTEREST | THERASIS, INC. | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | ADORA3 2041/4885SLC22A2 1401/4885SLC22A1 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.